302 related articles for article (PubMed ID: 18951691)
1. Bioluminescent evaluation of the therapeutic effects of total body irradiation in a murine hematological malignancy model.
Inoue Y; Izawa K; Kiryu S; Kobayashi S; Tojo A; Ohtomo K
Exp Hematol; 2008 Dec; 36(12):1634-41. PubMed ID: 18951691
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of disease progression by bioluminescence imaging and magnetic resonance imaging in an animal model of hematologic malignancy.
Inoue Y; Izawa K; Tojo A; Nomura Y; Sekine R; Oyaizu N; Ohtomo K
Exp Hematol; 2007 Mar; 35(3):407-15. PubMed ID: 17309821
[TBL] [Abstract][Full Text] [Related]
3. Light emission requires exposure to the atmosphere in ex vivo bioluminescence imaging.
Inoue Y; Izawa K; Tojo A; Sekine R; Okubo T; Ohtomo K
Mol Imaging; 2006; 5(2):53-6. PubMed ID: 16954018
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
5. Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1).
Loewenthal E; Weiss L; Samuel S; Or R; Slavin S
Bone Marrow Transplant; 1993 Aug; 12(2):109-13. PubMed ID: 8401354
[TBL] [Abstract][Full Text] [Related]
6. Optimal time interval between myeloablative whole body irradiation and reconstitution with syngeneic bone marrow graft.
Weiss L; Bullorsky E; Ashkenazi YJ; Slavin S
Bone Marrow Transplant; 1988 May; 3(3):207-10. PubMed ID: 3048487
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantation.
Hixon JA; Blazar BR; Anver MR; Wiltrout RH; Murphy WJ
Biol Blood Marrow Transplant; 2001; 7(3):136-43. PubMed ID: 11302547
[TBL] [Abstract][Full Text] [Related]
8. An immunocompetent murine model of metastatic mammary cancer accessible to bioluminescence imaging.
Shibata MA; Shibata E; Morimoto J; Eid NA; Tanaka Y; Watanabe M; Otsuki Y
Anticancer Res; 2009 Nov; 29(11):4389-95. PubMed ID: 20032383
[TBL] [Abstract][Full Text] [Related]
9. The kinetics of immunologic and hematologic recovery in mice after lethal total body irradiation and reconstitution with syngeneic bone marrow cells treated or untreated with mafosfamide (ASTA Z 7654).
Skórski T; Kawalec M; Hoser G; Ratajczak M; Gnatowski B; Kawiak J
Bone Marrow Transplant; 1988 Nov; 3(6):543-51. PubMed ID: 2905613
[TBL] [Abstract][Full Text] [Related]
10. IL-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation.
Chen T; Burke KA; Zhan Y; Wang X; Shibata D; Zhao Y
Exp Hematol; 2007 Feb; 35(2):203-13. PubMed ID: 17258069
[TBL] [Abstract][Full Text] [Related]
11. Gaussia luciferase for bioluminescence tumor monitoring in comparison with firefly luciferase.
Inoue Y; Sheng F; Kiryu S; Watanabe M; Ratanakanit H; Izawa K; Tojo A; Ohtomo K
Mol Imaging; 2011 Oct; 10(5):377-85. PubMed ID: 21521553
[TBL] [Abstract][Full Text] [Related]
12. Effects of ex vivo activated immune cells on syngeneic and semi-allogeneic bone marrow transplantation in mice.
Yang G; Tan J; Wei G; Deng Y; Chen H; Yang D
Transpl Immunol; 2006 Nov; 16(3-4):166-71. PubMed ID: 17138049
[TBL] [Abstract][Full Text] [Related]
13. The effect of syngeneic marrow injection upon recovery in sub- and near-lethally irradiated mice.
Boggs SS; Boggs DR; Patrene KD
Exp Hematol; 1989 Jun; 17(5):449-54. PubMed ID: 2653857
[TBL] [Abstract][Full Text] [Related]
14. Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice.
Sarraf-Yazdi S; Mi J; Dewhirst MW; Clary BM
J Surg Res; 2004 Aug; 120(2):249-55. PubMed ID: 15234220
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dose homogenization and radiation carcinogenesis risk in total body irradiation for bone marrow transplantation.
Oysul K; Dirican B; Beyzadeoglu M; Sürenkok S; Arpaci F; Pak Y
Neoplasma; 2003; 50(5):372-6. PubMed ID: 14628091
[TBL] [Abstract][Full Text] [Related]
16. Radiation protocols determine acute graft-versus-host disease incidence after allogeneic bone marrow transplantation in murine models.
Schwarte S; Bremer M; Fruehauf J; Sorge Y; Skubich S; Hoffmann MW
Int J Radiat Biol; 2007 Sep; 83(9):625-36. PubMed ID: 17654104
[TBL] [Abstract][Full Text] [Related]
17. Survival of mammary epithelial cells from virgin female BALB/c mice following in vivo gamma irradiation.
Adams LM; Ethier SP; Ullrich RL
Radiat Res; 1984 Nov; 100(2):264-72. PubMed ID: 6387778
[TBL] [Abstract][Full Text] [Related]
18. Whole body X-irradiation and repopulation with syngeneic bone marrow have no significant effect on basophils and mast cell compartment of murine lymph nodes.
Włodarski KH
Arch Immunol Ther Exp (Warsz); 1988; 36(4):433-7. PubMed ID: 3074742
[TBL] [Abstract][Full Text] [Related]
19. Radioprotective effect of whole-body hyperthermia on mice exposed to lethal doses of total-body gamma irradiation.
Patil MS; Kaklij GS; Poduval TB; Singh BB
Indian J Exp Biol; 1996 Sep; 34(9):842-4. PubMed ID: 9014515
[TBL] [Abstract][Full Text] [Related]
20. Photoactivable bioluminescent probes for imaging luciferase activity.
Shao Q; Jiang T; Ren G; Cheng Z; Xing B
Chem Commun (Camb); 2009 Jul; (27):4028-30. PubMed ID: 19568622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
